TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
The current TG Therapeutics(TGTX) stock price is $31.71, with a market capitalization of 5.03B. The stock trades at a price-to-earnings (P/E) ratio of 11.97.
On 2025-12-01, TG Therapeutics(TGTX) stock traded between a low of $31.61 and a high of $33.25. Shares are currently priced at $31.71, which is +0.3% above the low and -4.6% below the high.
The TG Therapeutics(TGTX)'s current trading volume is 1.58M, compared to an average daily volume of 1.84M.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $46.48 at its peak.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $46.48 at its peak.
TGTX News
Image source: The Motley Fool. Nov. 3, 2025 at 11:56 a.m. ET Call participants Chief Executive Officer — Michael Weiss Chief Commercial Officer — Adam Waldman...
